BEVACIZUMAB VERSUS RANIBIZUMAB FOR AGE-RELATED MACULAR DEGENERATION: EARLY RESULTS OF A PROSPECTIVE DOUBLE-MASKED, RANDOMIZED CLINICAL TRIAL : Evidence-Based Ophthalmology

Journal Logo

You can read the full text of this article if you:

Access through Ovid
CLINICAL STUDIES

BEVACIZUMAB VERSUS RANIBIZUMAB FOR AGE-RELATED MACULAR DEGENERATION: EARLY RESULTS OF A PROSPECTIVE DOUBLE-MASKED, RANDOMIZED CLINICAL TRIAL

Berger, Alan R. MD; Caissie, Mathieu MD

Author Information
Evidence-Based Ophthalmology: July 2010 - Volume 11 - Issue 3 - p 156-157
doi: 10.1097/IEB.0b013e3181e47287
  • Buy
© 2010 Lippincott Williams & Wilkins, Inc.